These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6625060)

  • 1. Effect of chemotherapy on experimental pulmonary schistosomiasis.
    de Almeida MA; Andrade ZA
    Am J Trop Med Hyg; 1983 Sep; 32(5):1049-54. PubMed ID: 6625060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative chemotherapy and resistance to reinfection in murine schistosomiasis.
    Andrade ZA; Azevedo de Brito P
    Am J Trop Med Hyg; 1982 Jan; 31(1):116-21. PubMed ID: 7058973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of oral therapy of mansonial schistosomiasis in the Sudan using single and multiple doses of hycanthone and oxamniquine drugs.
    Magzoub M; Adam SE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):382-7. PubMed ID: 682120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis].
    Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK
    AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH; Bowry HN; Roberts JM; Thuku JJ
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study.
    Saéz-Alquézar A; Ohtsuki N; Sette Júnior H; Magnanelli AC; Raia S; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):105-10, 225-31. PubMed ID: 7455503
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental chemotherapy of Schistosoma curassoni in mice.
    Vercruysse J; Southgate VR; Rollinson D; Hilderson H
    Parasitol Res; 1989; 75(7):559-62. PubMed ID: 2771923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Schistosoma mansoni transmission by chemotherapy in St. Lucia. I. Results in man.
    Cook JA; Jordan P; Bartholomew RK
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):887-93. PubMed ID: 907051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal hepatic necrosis in association with hycanthone.
    Hatchuel W
    S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 14. Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy.
    Martinelli R; Noblat AC; Brito E; Rocha H
    Kidney Int; 1989 May; 35(5):1227-33. PubMed ID: 2504987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute experimental schistosomiasis.
    Andrade ZA; de Azevedo TM
    Mem Inst Oswaldo Cruz; 1989; 84(4):477-84. PubMed ID: 2487444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial with hycanthone in the treatment of schistosomiasis mansoni].
    Huggins D
    An Inst Hig Med Trop (Lisb); 1974; 2(1-4):553-9. PubMed ID: 4462403
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic efficacy of oral oxamniquine in the toxemic form of schistosomiasis mansoni: treatment of eleven individuals from two families, and experimental study.
    Lambertucci JR; Pedroso ER; de Souza DW; de Lima DP; Neves J; Salazar HM; Marinho RP; da Costa Rocha MO; Coelho PM; de Lima Costa MF; Greco DB
    Am J Trop Med Hyg; 1980 Jan; 29(1):50-3. PubMed ID: 7352627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hycanthone in experimental schistosomiasis studies on liver pathology in mice treated with one and two doses.
    Farag HF; Guirguis RS; Sherif A; Hanna AT
    J Egypt Med Assoc; 1976; 59(5-6):439-47. PubMed ID: 1032313
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of oxamniquine on some biological features of schistosomiasis in white mice.
    Hammouda NA; El-Ridi AM; Abu Senna HO; Nasr NT; El-Sawi MF; El-Sawi M; Salama MM
    J Egypt Soc Parasitol; 1983 Jun; 13(1):147-53. PubMed ID: 6631092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.